Serum levels of AEAbs IgM were significantly lower in T2D group than in controls (0.34 ± 0.03 vs. 0.18 ± 0.01; p = 0.001; Figure 2C). This evidence concerns the gene CD40LG and type 2 diabetes mellitus.